Financial Metrics
Operational Facts
Stakeholder Positions
Information Gaps
Core Strategic Question
Structural Analysis
Applying the Jobs-to-be-Done lens reveals that users do not want a chat with a doctor; they want immediate medical reassurance and a path to treatment. The current model is constrained by the linear relationship between doctor availability and revenue. Utilizing the Value Chain framework, the primary cost driver is the human doctor. Shifting the triage function to AI changes the cost structure from variable to fixed, allowing for exponential scaling.
Strategic Options
| Option | Rationale | Trade-offs |
|---|---|---|
| AI-First B2B Triage | Integrate AI into the patient intake process for insurance companies to reduce unnecessary clinic visits. | Requires high integration with insurer systems; reduces direct consumer brand control. |
| Premium AI-Doctor Hybrid | Offer AI as a free first step with a paid human doctor escalation for complex cases. | Maintains brand trust; limits the speed of total automation. |
| Arabic Medical LLM Licensing | Commercialize the 450 million word dataset by licensing it to global health tech firms. | Generates high-margin revenue; risks enabling future competitors. |
Preliminary Recommendation
Altibbi must pursue the AI-First B2B Triage path. The unit economics of B2C telehealth in the MENA region are hindered by high customer acquisition costs and low willingness to pay. By embedding AI triage into insurance workflows, the company secures predictable revenue and solves the primary pain point for the largest payers in the market: over-utilization of emergency rooms for minor ailments.
Critical Path
Key Constraints
Risk-Adjusted Strategy
The plan includes a manual override protocol for the first 12 months. Every AI-generated triage result will be reviewed by a human medical officer in the background to validate accuracy before the AI interacts directly with the patient in a high-stakes scenario. This ensures safety while the model matures.
Bottom Line Up Front
Altibbi must pivot immediately from a doctor-matching service to an AI-first triage platform. The current human-dependent model cannot scale to meet the needs of 20 million monthly users profitably. By prioritizing B2B integration with insurers, the company shifts from a volatile consumer play to a stable infrastructure provider for the regional healthcare system. The proprietary 450 million word Arabic dataset is the only defensible moat against global competitors. Success requires focusing resources on model accuracy rather than geographic expansion.
Dangerous Assumption
The analysis assumes that the 450 million words of existing content are sufficiently structured and accurate to train a medical-grade AI. If the underlying data contains legacy errors or lacks clinical rigor, the resulting model will produce hallucinations that create significant legal liability.
Unaddressed Risks
Unconsidered Alternative
The team did not evaluate a pivot to a hardware-software combination. Deploying AI-powered diagnostic kiosks in pharmacies would capture the large portion of the population that lacks reliable smartphone access but requires immediate medical guidance. This would provide a physical presence and a new stream of biometric data.
Verdict: APPROVED FOR LEADERSHIP REVIEW
Blue Tokai Coffee Roasters: "Brewing" the Business Model that Fits (A) custom case study solution
Faubourg: Maintaining Art de Vivre Despite Employee Turnover custom case study solution
Grameen America: Advancing Financial Inclusion Through Innovation custom case study solution
Into the Raging Sea: Final Voyage of the SS El Faro custom case study solution
Scale and Scope at Drake Real Estate Partners custom case study solution
ClearEyes Cataracts Clinic custom case study solution
boAt Lifestyle custom case study solution
New Zealand: Measuring What Matters custom case study solution
Intel® GrowthX: Partnering with Entrepreneurs for Growth custom case study solution
Buhler: Mobilizing Industry Around A Common Purpose custom case study solution
Alcaguete: The Challenge of Sustainable Growth custom case study solution
ECCO A/S - Global Value Chain Management custom case study solution
Corporate Venture Capital at Eli Lilly custom case study solution